孕期地塞米松暴露通过调控子代睾丸支持细胞Tbx2/Cx43参与精子发生异常
批准号:
82104312
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
陈光辉
依托单位:
学科分类:
药物毒理
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
陈光辉
中文摘要
精子发生异常严重威胁人类生殖健康,是男性不育的关键诱因。研究提示,由支持细胞构成的血睾屏障损伤是精子发生异常的重要原因,其发生与血睾屏障功能基因连接蛋白43(Cx43)等的低表达有关。我们近期发现,孕期地塞米松暴露(PDE)可致子代精子发生异常及睾丸Cx43低表达,然而其发生机制尚未明了。T-box转录因子2(Tbx2)是Cx43的转录抑制因子,而Tbx2表达受到表观遗传调控,其转录调控区存在糖皮质激素受体(GR)结合位点。据此我们推测:地塞米松激活GR并结合于Tbx2启动子区促进其表达;同时通过上调并招募P300至Tbx2启动子区,诱导Tbx2启动子区乙酰化水平增加,导致Tbx2高表达编程并延续至出生后,进而抑制支持细胞Cx43的表达,造成血睾屏障损伤和精子发生异常。本项目拟系统阐明PDE导致血睾屏障损伤的宫内编程机制,为探寻胎源性精子发生异常的毒性靶标和早期防治策略提供理论依据。
英文摘要
Abnormal spermatogenesis seriously threatens human reproductive health, which is the key cause of male infertility. Researches have suggested that blood-testis barrier damage composed of sertoli cell is a key factor affecting the abnormal spermatogenesis and related to the low expression of blood-testis barrier function gene, such as connexin 43 (Cx43) and its like. Recently, we discovered that prenatal dexamethasone exposure (PDE) could induce abnormal spermatogenesis in offspring and decreased expression of Cx43 in testis. However, the mechanism involved in blood-testis barrier damage remains unclear. T-box transcription factor 2 (Tbx2) is a transcriptional repressor of Cx43, the expression of which is subject to epigenetic regulation and there is a glucocorticoid receptor (GR) binding site in its transcriptional regulatory region. Based on preliminary results, we speculate that dexamethasone could activate GR and combine with Tbx2 promoter region to increase its expression; meanwhile, upregulate and recruite P300 to Tbx2 promoter region, which induces increased acetylation level of Tbx2 promoter region, thereby leading to a high Tbx2 expression programming that continues after birth. Subsequently, to inhibit Cx43 expression of sertoli cell and result in blood-testis barrier damage and abnormal spermatogenesis. This study aims to elucidate systematically the intrauterine programming mechanism of blood-testis barrier damage induced by PDE, and provide a theoretical basis for exploring toxicity targets and early prevention strategy of fetal-originated abnormal spermatogenesis.
合成类糖皮质激素地塞米松,临床广泛用于早产及妊娠相关疾病。但是,越来越多研究提示,孕期地塞米松暴露会导致子代出生体重降低,并引起多脏器的发育毒性及成年后疾病的易感。本室前期研究发现,孕期地塞米松暴露可以影响雄性子代睾丸间质细胞睾酮的合成与分泌。基于本项目,我们取得如下学术成果:1)不同时期、剂量和疗程的孕期地塞米松暴露对胎睾丸发育毒性的影响。孕期地塞米松暴露可致胎睾丸组织间质区域拓宽、生精小管数量减少;孕期地塞米松暴露导致支持细胞功能受损,以孕晚期、大剂量、多疗程最为显著,而间质细胞和精原细胞功能变化不显著;孕期地塞米松暴露可致睾丸支持细胞Notch信号通路激活而Wnt信号通路抑制。2)孕期地塞米松暴露通过调控子代睾丸支持细胞Tbx2/Cx43参与精子发生异常。我们动物和细胞实验发现地塞米松可以激活胎睾丸支持细胞的GR,一方面增加GR与Tbx2启动子区域的结合,另一方面上调并招募P300,升高Tbx2启动子区域的H3K9ac水平,该表观遗传机制在出生后持续存在,导致Tbx2表达升高,血睾屏障蛋白CX43表达降低,最终导致精子质量下降。此外,完成本项目原计划研究内容的同时,基于孕期地塞米松暴露大鼠模型及临床孕期地塞米松用药人群标本。我们对孕期地塞米松暴露对子代肾上腺功能低下的分子机制进行了探索,并发现PBMC中SF1启动子区低H3K27ac水平可作为孕期地塞米松暴露男性子代肾上腺功能低下的预警标志物。本项目证实孕期地塞米松暴露所致子代睾丸及肾上腺发育毒性的现象及分子机制,为指导孕期合理用药,解析国际“DOHaD”学说,寻找胎源性疾病的早期预警标志物提供了系统的实验证据及研究思路。在本项目的资助下,我们发表了SCI论文3篇,培养了研究生2名。
国内基金
海外基金